NCT00574652
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Cryoglobulinemia, +13 more
- Locations
-
- Hôpital de la Pitié Paris, France
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,013 public trials
2,032 recruiting studies
Immunoproliferative Disorders trial results
NCT02518555
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT05972577
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Anemia, +49 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT01067287
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Rambam Medical Center Haifa, Israel
NCT05474170
- Conditions
- Cardiopulmonary Arrest, Cardiovascular Diseases, Heart Arrest, +14 more
- Locations
-
- Swiss Prehospital Research Day Neuchâtel, Canton of Neuchâtel, Switzerland
NCT01502085
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
Completed
A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531
NCT01813227
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
NCT04673617
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Artiva Clinical Trial Site Birmingham, Alabama, United States
- Artiva Clinical Trial Site Tucson, Arizona, United States
- Artiva Clinical Trial Site Orange, California, United States
- Artiva Clinical Trial Site San Diego, California, United States
NCT01723839
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
- Locations
-
- John Theurer Cancer Center at HackensackUMC Hackensack, New Jersey, United States
- Conditions
- Advanced Malignant Solid Neoplasm, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ependymoma, +81 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States